Meadowbrook Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.92M Buy
3,268
+1,718
+111% +$1.76M 4.22% 6
2026
Q1
$1.43M Sell
1,550
-1,785
-54% -$1.81M 1.89% 15
2025
Q4
$3.58M Buy
3,335
+2,101
+170% +$2.01M 4.09% 6
2025
Q3
$942K Buy
+1,234
New +$918K 0.98% 28

Other funds holding LLY

Meadowbrook Wealth Management's LLY Position: Q2 2026 in Review

Meadowbrook Wealth Management increased its Eli Lilly (LLY) stake by 111% in Q2 2026, buying an estimated $1.76M and bringing the position to 3,268 shares worth $3.92M. The position accounts for 4.22% of the portfolio, ranked #6.

Meadowbrook Wealth Management first reported a position in LLY in Q3 2025 and has held it in 4 quarters since. 2,861 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Meadowbrook Wealth Management held 3,268 shares of Eli Lilly worth $3.92M as of Q2 2026.
  • Meadowbrook Wealth Management bought 1,718 Eli Lilly shares in Q2 2026, an estimated $1.76M.
  • Eli Lilly made up 4.22% of Meadowbrook Wealth Management's portfolio in Q2 2026, its #6 holding.
  • Meadowbrook Wealth Management first reported a position in Eli Lilly in Q3 2025 and has held it in 4 quarters since.
  • 2,861 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Meadowbrook Wealth Management's 13F filing for Q2 2026, filed 6 Jul 2026.